CELEBRATING & REWARDING
Celebrating the Best and Brightest
Founded by the Science Talent Search alumni and deeply committed to STEM education, Regeneron prioritizes the need to support young scientists who are generating ideas and solutions to address global challenges.
The Regeneron Science Talent Search (STS), a program of Society for Science & the Public, is the nation’s most prestigious pre-college science and mathematics competition. Established in 1942, it recognizes the best and brightest young scientists for demonstrating exceptional scientific leadership potential.
Each year, approximately 1,800 high school seniors enter the Regeneron STS. Three hundred Regeneron STS scholars are selected and they and their schools are awarded $2,000 each, totaling approximately $1.2 million in awards. From that pool of scholars, 40 finalists receive an all-expenses-paid trip to Washington, D.C., where they compete in a rigorous judging process for an additional $1.8 million in awards, with a top prize of $250,000.
Check out the most recent news about the Regeneron Science Talent Search and learn more about Regeneron’s 10-year, $100 million commitment.
SCIENCE AND ENGINEERING FAIR
Expanding our global STEM commitment
The Regeneron International Science and Engineering Fair (ISEF), a program of Society for Science & the Public, is the world's largest pre-college science and engineering competition. Established in 1950, it gives the world's noteworthy young scientists a global stage to share their outstanding STEM research, and compete for nearly $5 million in awards, prizes and scholarships.
Each year, over 175,000 students compete in the Society's more than 420 affiliated high school science fairs around the world. Top winners earn the right to compete at ISEF where nearly 2,000 finalists are judged in 21 different categories including biochemistry, behavioral and social sciences, environmental engineering, mathematics, robotics and intelligent machines, systems software and translational medical science.
Learn more about news related to the Regeneron International Science and Engineering Fair and Regeneron’s commitment of approximately $24 million over a five-year period.
OUR LEGACY WITH STS
We are proud to have several STS alumni among our employee base, including Len Schleifer, MD, PhD, our Co-founder, President and CEO, and George Yancopoulos, MD, PhD, our Co-founder, President and Chief Scientific Officer.
READY FOR ISEF 2020
We are looking forward to kicking off our support of ISEF with the 2020 Regeneron ISEF on May 10-15, 2020 in Anaheim, CA.
- George D. Yancopoulos, MD, PhD
Founding Scientist, Co-founder, President and Chief Scientific Officer
LEONARD S. SCHLEIFER, MD, PhD
Founder, President and Chief Executive Officer, Regeneron
Chairman of the Board from 1990-1994
Len grew up in Queens, New York, in a middle-class family, with parents and teachers who inspired his passion for science and entrepreneurship. Len's high school math teacher encouraged him to submit a project to the Westinghouse Science Talent Search in 1970, helping to launch him on the path to his current position.
He earned his MD and PhD in Pharmacology from the University of Virginia and became a licensed physician certified in neurology. While working as a practicing neurologist and professor at Cornell Medical School, Len became frustrated with the lack of effective treatments for his patients with serious neurodegenerative diseases like Parkinson's and Alzheimer's. He wondered if new "biotechnology" could be harnessed to potentially make an impact for these patients, and many others.
Len founded Regeneron in 1988, with the vision of creating a company built entirely on science, where scientists are the heroes and everyone works toward the common goal of helping patients. He knew he needed a top-notch team and immediately recruited three Nobel Laureates to the Board, as well as George Yancopoulos, MD, PhD, a top scientist from Columbia University, to serve as the company's Founding Scientist. Thirty years later, Len's dream is a reality, and the Regeneron team is using their scientific prowess to consistently and repeatedly bring new medicines to people in need.
Len has always aimed to "pay it forward" by creating a legacy of scientific mentorship and empowerment. Regeneron has a long-standing and deep commitment to STEM (Science, Technology, Engineering and Math) education and fostering the future of biomedicine. Through immersive programs, Regeneron strives to support the next generation of groundbreaking minds that will continue to change the world through scientific discovery.
Len is so proud that the world's preeminent science competition for high school students will now be known as the Regeneron Science Talent Search.
GEORGE D. YANCOPOULOS, MD, PhD
Founding Scientist and Chief Scientific Officer, Regeneron
President, Regeneron Laboratories
George joined Regeneron as the company's Founding Scientist and now serves as the Chief Scientific Officer and President. His interest in science started with the stars — specifically with the Russian American space race that was headlining the news during his childhood.
The son of Greek immigrants in New York City, George attended the Bronx High School of Science, where he wanted to be like the heroes at school and compete in the Westinghouse Science Talent Search. With the help of his teacher-mentor, Mrs. Strom, George would arrive to school at 5:30 each morning to work on his project, a top winner in the 1976 Science Talent Search. This was a life-changing experience that confirmed he would commit to a career in the sciences.
After graduating as valedictorian at Bronx Science and at Columbia University, George received MD and PhD degrees from Columbia University's College of Physicians & Surgeons. At Columbia, he served as legendary geneticist Dr. Fred Alt's first postdoctoral student, working in molecular immunology. In 1989, Len Schleifer, MD, PhD, recruited George to Regeneron. Before taking the job, George's dad insisted on interviewing Len to ensure that his brilliant son was making the right decision in joining the then-fledgling biotech company. At the time, many of his academic peers counseled him against going to "the business side" of science — fearing his promising start in academia would be all for naught. George says he never forgets those well-intentioned words, and they are part of what's motivated him to work so hard to keep that from happening.
As it turned out, George has received more than 100 patents, including several relating to Regeneron's four FDA-approved drugs and its foundational technologies, including VelociGene? and VelocImmune?. In 2004, he was elected to the National Academy of Sciences, which is virtually unheard of for an industry scientist, and was the 11th most highly cited scientist in the world in the 1990s.
George wants to bring his success in the sciences full circle and is deeply committed to inspiring excitement about scientific careers through STEM (Science, Technology, Engineering and Math) education programs. George plays an active role in Regeneron's STEM commitments and lends his name to the George D. Yancopoulos Young Scientist Award given at the Westchester Science & Engineering Fair for student researchers whose passion for science may lead to the development of novel technologies or biological insights. He hopes that the Regeneron Science Talent Search will positively influence young scientists, just as it did for him when it was called the Westinghouse.